03 Sep 2015

Proposed Placement of Shares in Medtecs International Corporation Limited

Danny Lim, Chia Lee Fong and Caitlin Huang from the Capital Markets / Mergers & Acquisitions Practice Group are acting for Medtecs International Corporation Limited ("Company" and together with its subsidiaries, "Group"), which is listed on the Catalist Board of the Singapore Exchange Securities Trading Limited, in relation to its proposed private placement of 81,862,275 new ordinary shares ("Placement Shares") in the capital of the Company at an issue price of S$0.07 (US$0.04) per Placement Share, amounting to an aggregate consideration of approximately S$5.73 million (approximately US$4.09 million).

The Group is an integrated healthcare products and services provider in the Asia Pacific region, and manufacturer and distributor of medical consumables for the global healthcare industry. The Group has established a strong presence in the United States, Europe and Asia Pacific, and has offices and facilities across Asia – in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and the People's Republic of China.